DUBLIN — April 2, 2020 — Horizon Therapeutics plc (Nasdaq: HZNP) announced today that it has acquired Curzion Pharmaceuticals, Inc., a privately held development-stage biopharma company, and its development-stage oral...
Art Pappas will be on a panel titled “Update on Capital Availability for Indiana Companies” at Burrill’s Indiana Life Sciences Forum in Indianapolis, IN
News | 10. 21. 2008
